Semaglutide improved sperm morphology in obese men with type 2 diabetes mellitus and functional hypogonadism

Ähnliche Einträge

• Semaglutide improves treatment satisfaction and eating behaviour in Japanese patients with type 2 diabetes mellitus
  von: Yusuke Baba, et al.
  Veröffentlicht: (2024)
• Glucagon agonism in the treatment of metabolic diseases including type 2 diabetes mellitus and obesity
  von: Jonathan Brix Winther, et al.
  Veröffentlicht: (2024)
• The cost‐utility and budget impact analyses of Tirzepatide versus once‐weekly Semaglutide as add‐on therapy to metformin in patients with type 2 diabetes mellitus in China
  von: Sihua Wang, et al.
  Veröffentlicht: (2025)
• Impact of Semaglutide on fat mass, lean mass and muscle function in patients with obesity: The SEMALEAN study
  von: Mathieu Alissou, et al.
  Veröffentlicht: (2025)
• Impact of bariatric surgery on glycaemic and metabolic outcomes in people with obesity and type 2 diabetes mellitus: A meta‐analysis
  von: Xu Han, et al.
  Veröffentlicht: (2025)